Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Kansas City, MO – FDA Inspections
Inspection records and compliance data for Linde Inc. in Kansas City, Missouri. 1 FDA inspection on record, last inspected October 24, 2013. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Kansas City, Missouri, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected October 24, 2013.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 24, 2013 | NAI | Human Drugs · Drug Quality Assurance | 856011 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1921174
Address
6701 Saint John Ave, Kansas City, Missouri 64123, United States
Country
United States
ID: 460c8e01-da83-4bfa-866d-3cd8dab83ef1